Advertisement

Pediatric Cardiology

, Volume 38, Issue 2, pp 324–331 | Cite as

NT-proBNP as Marker of Ventricular Dilatation and Pulmonary Regurgitation After Surgical Correction of Tetralogy of Fallot: A MRI Validation Study

  • Annalisa Paolino
  • Tarique Hussain
  • Antonio Pavon
  • Maria Nieves Velasco
  • Sergio Uribe
  • Antonio Ordoñez
  • Israel ValverdeEmail author
Original Article

Abstract

The goal of this study is to evaluate whether NT-proBNP plasma levels may help as a screening biomarker for monitoring right ventricular dilatation, pulmonary regurgitation and the onset of heart failure in patients with repaired Tetralogy of Fallot. Our single-centre observational prospective study involved 43 patients (15.1 years, SD = 8) with corrected Tetralogy of Fallot. Data collection included: clinical parameters (electrocardiogram, chest X-ray, NYHA scale, time since last surgery), biochemistry (NT-proBNP levels) and MRI values (ventricular volumetry, pulmonary flow assessment). Mean time since last surgery was 13.5 years (SD = 7.8). There was a statistically significant correlation between the NT-proBNP levels (187.4 pg/ml, SD = 154.9) and right ventricular dilatation for both the right ventricular end-diastolic volume (124.9 ml/m2, SD = 31.2) (Pearson = 0.19, p < 0.01) and end-systolic volume (56.1 ml/m2, SD = 18.8) (Pearson = 0.21, p < 0.01) and also with the pulmonary regurgitation fraction (36.5%, SD = 16, Pearson = 0.12, p < 0.01). No significant correlation was found between NT-proBNP and right ventricular ejection fraction (54.6%, SD = 10.6, Pearson = −0.07), left ventricular ejection fraction (59.9%, SD = 7.1, Pearson = −0.18) or any clinical parameters. The receiver operating curve analysis evidenced that a NT-proBNP cut-off value above 133.2 pg/ml predicted the presence of dilated right ventricular end-diastolic and end-systolic volumes over centile 95 (sensitivity 82 and 83% and specificity 93 and 79%, respectively). In conclusion, in patients with surgically corrected Tetralogy of Fallot, NT-proBNP levels correlate with right ventricular dilatation and the degree of pulmonary regurgitation. Ambulatory determination of NT-proBNP might be an easy, readily available and cost-effective alternative for MRI follow-up evaluation of these patients.

Keywords

NT-proBNP Tetralogy of Fallot Congenital heart disease Magnetic resonance imaging 

Notes

Acknowledgements

The authors acknowledge the invaluable work and collaboration of the paediatric cardiology team including Dr. Santos, Dr. Gavilan, Dr. Grueso, Dr. Moruno, Dr. Garcia-Angleu, Dr. Coserria and the Magnetic Resonance Unit team including Mr. Alfonso Soto, Dr. Serrano, Dr. Navarro, Dr. Fernandez-Cruz.

Financial Support

This research has been financed by Institute of Health Carlos III—FIS research Grant Number PI14/00180 from the Spanish Ministry of Science and Innovation.

Compliance with Ethical Standards

Conflict of interest

All the authors had full access to the data. They take responsibility for the data presented and their discussed interpretation. None of the authors have any conflicts of interest to declare.

Ethical Standards

The authors assert that all procedures contributing to this work comply with the Helsinki Declaration of 1975, as revised in 2008, and the local research ethics committee approved this prospective study (Ethics Number 2012PI/159). Informed consent was obtained from patients and legal guardians, as appropriate.

References

  1. 1.
    Murphy JG, Gersh BJ, Mair DD, Fuster V, McGoon MD, Ilstrup DM, McGoon DC, Kirklin JW, Danielson GK (1993) Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med 329:593–599CrossRefPubMedGoogle Scholar
  2. 2.
    Nollert G, Fischlein T, Bouterwek S, Bohmer C, Klinner W, Reichart B (1997) Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair. J Am Coll Cardiol 30:1374–1383CrossRefPubMedGoogle Scholar
  3. 3.
    Babu-Narayan SV, Kilner PJ, Li W, Moon JC, Goktekin O, Davlouros PA, Khan M, Ho SY, Pennell DJ, Gatzoulis MA (2006) Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome. Circulation 113:405–413CrossRefPubMedGoogle Scholar
  4. 4.
    Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G (2005) Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol 95:779–782CrossRefPubMedGoogle Scholar
  5. 5.
    Westhoff-Bleck M, Girke S, Breymann T, Lotz J, Pertschy S, Tutarel O, Roentgen P, Bertram H, Wessel A, Schieffer B, Meyer GP (2011) Pulmonary valve replacement in chronic pulmonary regurgitation in adults with congenital heart disease: impact of preoperative QRS-duration and NT-proBNP levels on postoperative right ventricular function. Int J Cardiol 151:303–306CrossRefPubMedGoogle Scholar
  6. 6.
    Buechel ER, Dave HH, Kellenberger CJ, Dodge-Khatami A, Pretre R, Berger F, Bauersfeld U (2005) Remodelling of the right ventricle after early pulmonary valve replacement in children with repaired tetralogy of Fallot: assessment by cardiovascular magnetic resonance. Eur Heart J 26:2721–2727CrossRefPubMedGoogle Scholar
  7. 7.
    Dave HH, Buechel ER, Dodge-Khatami A, Kadner A, Rousson V, Bauersfeld U, Pretre R (2005) Early insertion of a pulmonary valve for chronic regurgitation helps restoration of ventricular dimensions. Ann Thorac Surg 80:1615–1620 (discussion 1620–1611) CrossRefPubMedGoogle Scholar
  8. 8.
    Attili AK, Parish V, Valverde I, Greil G, Baker E, Beerbaum P (2011) Cardiovascular MRI in childhood. Arch Dis Child 96:1147–1155CrossRefPubMedGoogle Scholar
  9. 9.
    Geva T (2011) Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support. J Cardiovasc Magn Reson 13:9CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Ntsinjana HN, Hughes ML, Taylor AM (2011) The role of cardiovascular magnetic resonance in pediatric congenital heart disease. J Cardiovasc Magn Reson 13:51CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Levin ER, Gardner DG, Samson WK (1998) Natriuretic peptides. N Engl J Med 339:321–328CrossRefPubMedGoogle Scholar
  12. 12.
    Eindhoven JA, van den Bosch AE, Ruys TP, Opic P, Cuypers JA, McGhie JS, Witsenburg M, Boersma E, Roos-Hesselink JW (2013) N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease. J Am Coll Cardiol 62:1203–1212CrossRefPubMedGoogle Scholar
  13. 13.
    Cheung EWY, Lam WWM, Chiu CSW, Chau AKT, Cheung SCW, Y-f Cheung (2007) Plasma brain natriuretic peptide levels, right ventricular volume overload and exercise capacity in adolescents after surgical repair of tetralogy of Fallot. Int J Cardiol 121:155–162CrossRefPubMedGoogle Scholar
  14. 14.
    Khositseth A, Manop J, Khowsathit P, Siripornpitak S, Pornkul R, Lolekha P, Attanawanich S (2007) N-terminal pro-brain natriuretic peptide as a marker in follow-up patients with tetralogy of Fallot after total correction. Pediatr Cardiol 28:333–338CrossRefPubMedGoogle Scholar
  15. 15.
    van den Berg J, Strengers JL, Wielopolski PA, Hop WC, Meijboom FJ, de Rijke YB, Boomsma F, Bogers AJ, Pattynama PM, Helbing WA (2009) Assessment of biventricular functional reserve and NT-proBNP levels in patients with RV volume overload after repair of tetralogy of Fallot at young age. Int J Cardiol 133:364–370CrossRefPubMedGoogle Scholar
  16. 16.
    Grutter G, Alfieri S, Parisi F (2013) Brain natriuretic peptide level in a small series of children and grown-ups with congenital heart defects with chronic cardiac failure. Cardiol Young 23:447–449CrossRefPubMedGoogle Scholar
  17. 17.
    Dodge-Khatami A, Buchel EV, Knirsch W, Kadner A, Rousson V, Dave HH, Bauersfeld U, Pretre R (2006) Brain natriuretic peptide and magnetic resonance imaging in tetralogy with right ventricular dilatation. Ann Thorac Surg 82:983–988CrossRefPubMedGoogle Scholar
  18. 18.
    Norozi K, Buchhorn R, Kaiser C, Hess G, Grunewald RW, Binder L, Wessel A (2005) Plasma N-terminal pro-brain natriuretic peptide as a marker of right ventricular dysfunction in patients with tetralogy of Fallot after surgical repair. Chest 128:2563–2570CrossRefPubMedGoogle Scholar
  19. 19.
    Omland T, Sabatine MS, Jablonski KA, Rice MM, Hsia J, Wergeland R, Landaas S, Rouleau JL, Domanski MJ, Hall C, Pfeffer MA, Braunwald E, Investigators P (2007) Prognostic value of B-type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial. J Am Coll Cardiol 50:205–214CrossRefPubMedGoogle Scholar
  20. 20.
    Emdin M, Passino C, Prontera C, Fontana M, Poletti R, Gabutti A, Mammini C, Giannoni A, Zyw L, Zucchelli G, Clerico A (2007) Comparison of brain natriuretic peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure. Clin Chem 53:1289–1297CrossRefPubMedGoogle Scholar
  21. 21.
    Du Bois D, Du Bois EF (1989) A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 5:303–311 (discussion 312–303) PubMedGoogle Scholar
  22. 22.
    Buechel EV, Kaiser T, Jackson C, Schmitz A, Kellenberger CJ (2009) Normal right- and left ventricular volumes and myocardial mass in children measured by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 11:19CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Frigiola A, Tsang V, Bull C, Coats L, Khambadkone S, Derrick G, Mist B, Walker F, van Doorn C, Bonhoeffer P, Taylor AM (2008) Biventricular response after pulmonary valve replacement for right ventricular outflow tract dysfunction: is age a predictor of outcome? Circulation 118:S182–S190CrossRefPubMedGoogle Scholar
  24. 24.
    Oosterhof T, van Straten A, Vliegen HW, Meijboom FJ, van Dijk AP, Spijkerboer AM, Bouma BJ, Zwinderman AH, Hazekamp MG, de Roos A, Mulder BJ (2007) Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation 116:545–551CrossRefPubMedGoogle Scholar
  25. 25.
    Geva T (2011) Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support. J Cardiovasc Magn Reson 13:9CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Cheung EW, Lam WW, Chiu CS, Chau AK, Cheung SC, Cheung YF (2007) Plasma brain natriuretic peptide levels, right ventricular volume overload and exercise capacity in adolescents after surgical repair of tetralogy of Fallot. Int J Cardiol 121:155–162CrossRefPubMedGoogle Scholar
  27. 27.
    Schou M, Gustafsson F, Nielsen PH, Madsen LH, Kjaer A, Hildebrandt PR (2007) Unexplained week-to-week variation in BNP and NT-proBNP is low in chronic heart failure patients during steady state. Eur J Heart Fail 9:68–74CrossRefPubMedGoogle Scholar
  28. 28.
    Bruins S, Fokkema MR, Romer JW, Dejongste MJ, van der Dijs FP, van den Ouweland JM, Muskiet FA (2004) High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem 50:2052–2058CrossRefPubMedGoogle Scholar
  29. 29.
    Cantinotti M, Law Y, Vittorini S, Crocetti M, Marco M, Murzi B, Clerico A (2014) The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update. Heart Fail Rev 19:727–742CrossRefPubMedGoogle Scholar
  30. 30.
    Eindhoven JA, Menting ME, van den Bosch AE, Cuypers JA, Ruys TP, Witsenburg M, McGhie JS, Boersma E, Roos-Hesselink JW (2014) Associations between N-terminal pro-B-type natriuretic peptide and cardiac function in adults with corrected tetralogy of Fallot. Int J Cardiol 174:550–556CrossRefPubMedGoogle Scholar
  31. 31.
    Ye JJ, Shu Q, Liu XW, Gu WZ, Yu J, Jiang GP (2014) Noninvasive perioperative evaluation of right ventricular function in children with tetralogy of Fallot. Artif Organs 38:41–47CrossRefPubMedGoogle Scholar
  32. 32.
    Tzemos N, Harris L, Carasso S, Subira LD, Greutmann M, Provost Y, Redington AN, Rakowski H, Siu SC, Silversides CK (2009) Adverse left ventricular mechanics in adults with repaired tetralogy of Fallot. Am J Cardiol 103:420–425CrossRefPubMedGoogle Scholar
  33. 33.
    Nir A, Lindinger A, Rauh M, Bar-Oz B, Laer S, Schwachtgen L, Koch A, Falkenberg J, Mir TS (2009) NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies. Pediatr Cardiol 30:3–8CrossRefPubMedGoogle Scholar
  34. 34.
    Mir TS, Laux R, Hellwege HH, Liedke B, Heinze C, von Buelow H, Laer S, Weil J (2003) Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic peptide in healthy neonates: marked and rapid increase after birth. Pediatrics 112:896–899CrossRefPubMedGoogle Scholar
  35. 35.
    Koch A, Singer H (2003) Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart 89:875–878CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Soldin SJ, Soldin OP, Boyajian AJ, Taskier MS (2006) Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals. Clin Chim Acta 366:304–308CrossRefPubMedGoogle Scholar
  37. 37.
    Lin CW, Zeng XL, Jiang SH, Wu T, Wang JP, Zhang JF, Ou YH (2013) Role of the NT-proBNP level in the diagnosis of pediatric heart failure and investigation of novel combined diagnostic criteria. Exp Ther Med 6:995–999PubMedPubMedCentralGoogle Scholar
  38. 38.
    Santaguida PL, Don-Wauchope AC, Oremus M, McKelvie R, Ali U, Hill SA, Balion C, Booth RA, Brown JA, Bustamam A, Sohel N, Raina P (2014) BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review. Heart Fail Rev 19:453–470CrossRefPubMedGoogle Scholar
  39. 39.
    Waldo SW, Beede J, Isakson S, Villard-Saussine S, Fareh J, Clopton P, Fitzgerald RL, Maisel AS (2008) Pro-B-type natriuretic peptide levels in acute decompensated heart failure. J Am Coll Cardiol 51:1874–1882CrossRefPubMedGoogle Scholar
  40. 40.
    Luers C, Schmidt A, Wachter R, Fritzsche F, Sutcliffe A, Kleta S, Zapf A, Hagenah G, Binder L, Maisch B, Pieske B (2010) Serial NT-proBNP measurements for risk stratification of patients with decompensated heart failure. Herz 35:488–495CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Paediatric Cardiology UnitHospital Virgen del RocioSevilleSpain
  2. 2.Division of Imaging Sciences and Biomedical Engineering, The Rayne Institute, St. Thomas’ HospitalKing’s College LondonLondonUK
  3. 3.Department of Paediatrics, Southwestern Medical CenterUniversity of TexasDallasUSA
  4. 4.Neonate Intensive Care UnitHospital Virgen del RocioSevilleSpain
  5. 5.Radiology Department and Biomedical Imaging Center, School of MedicinePontificia Universidad Católica de ChileSantiagoChile
  6. 6.Cardiovascular Pathology Unit, Institute of Biomedicine of Seville, IBISHospital Virgen del Rocio/CSIC/University of SevilleSevilleSpain

Personalised recommendations